Jiuqiang Biotech announced that the company and its wholly-owned subsidiary Beijing Meixinyue Medical Devices Co., Ltd. recently received the “Medical Device Registration Certificate” issued by the Beijing Drug Administration. The product names are alanine aminotransferase assay kit and D-dimer assay kit. The registration category is Class II, and the registration certificate is valid from the date of approval until December 21, 2030 and December 18, 2030. The acquisition of the medical device registration certificate for the above products has enriched the variety of the company's product line in the field of biochemistry and blood clotting in vitro diagnosis, which is conducive to further enhancing the company's core competitiveness and market expansion capabilities, and will have a positive impact on the company's future operations.

Jiuqiang Biotech announced that the company and its wholly-owned subsidiary Beijing Meixinyue Medical Devices Co., Ltd. recently received the “Medical Device Registration Certificate” issued by the Beijing Drug Administration. The product names are alanine aminotransferase assay kit and D-dimer assay kit. The registration category is Class II, and the registration certificate is valid from the date of approval until December 21, 2030 and December 18, 2030. The acquisition of the medical device registration certificate for the above products has enriched the variety of the company's product line in the field of biochemistry and blood clotting in vitro diagnosis, which is conducive to further enhancing the company's core competitiveness and market expansion capabilities, and will have a positive impact on the company's future operations.